How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/ergocalciferol-capsules.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Ergocalciferol Capsules — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ergocalciferol Capsules (Ergocalciferol Capsules) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Provitamin D2 Compound [EPC].

marketed Provitamin D2 Compound [EPC] Small molecule Live · refreshed every 30 min

Target snapshot

Ergocalciferol Capsules (Ergocalciferol Capsules) — University of Texas Southwestern Medical Center.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Ergocalciferol Capsules TARGET	Ergocalciferol Capsules	University of Texas Southwestern Medical Center	marketed	Provitamin D2 Compound [EPC]
Drisdol	ERGOCALCIFEROL	Esjay Pharma	marketed	Provitamin D2 Compound [EPC]	25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial	1941-01-01
Vitamin D2	Vitamin D2	Wenhu Liu	marketed	Provitamin D2 Compound [EPC]

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Provitamin D2 Compound [EPC] class)

Esjay Pharma · 1 drug in this class
University of Texas Southwestern Medical Center · 1 drug in this class
Wenhu Liu · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Ergocalciferol Capsules — Competitive Intelligence Brief. https://druglandscape.com/ci/ergocalciferol-capsules. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing